The lower matrix protein pp65 is the principal viral antigen present in peripheral blood leukocytes during an active cytomegalovirus infection

scientific article published on 01 November 1992

The lower matrix protein pp65 is the principal viral antigen present in peripheral blood leukocytes during an active cytomegalovirus infection is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1099/0022-1317-73-11-2923
P698PubMed publication ID1331294

P2093author name stringThe TH
van Son WJ
Jahn G
Schmolke S
Grefte JM
van der Giessen M
Plachter B
van der Gun BT
P407language of work or nameEnglishQ1860
P921main subjectimmediate-early proteinsQ77944262
white blood cellQ42395
cytomegaloviral diseaseQ2076966
P304page(s)2923-2932
P577publication date1992-11-01
P1433published inJournal of General VirologyQ6295245
P1476titleThe lower matrix protein pp65 is the principal viral antigen present in peripheral blood leukocytes during an active cytomegalovirus infection
P478volume73 ( Pt 11)

Reverse relations

cites work (P2860)
Q39505954A sensitive method for quantifying cytomegalic endothelial cells in peripheral blood from cytomegalovirus-infected patients.
Q40010631A three-center European external quality control study of PCR for detection of cytomegalovirus DNA in blood
Q81258380Antigenemia for cytomegalovirus in renal transplantation: choosing a cutoff for the diagnosis criteria in cytomegalovirus disease
Q59335149CMV and EBV targets recognized by tumor-infiltrating B lymphocytes in pancreatic cancer and brain tumors
Q40958077Cell types involved in replication and distribution of human cytomegalovirus.
Q73287023Comparison of commercially available antibody reagents for the cytomegalovirus pp65 antigenemia assay
Q36545212Comparison of culture and the antigenemia assay for detection of cytomegalovirus in blood specimens submitted to a reference laboratory
Q28367797Cross-reactivity of Epstein-Barr virus-specific immunoglobulin M antibodies with cytomegalovirus antigens containing glycine homopolymers
Q33852522Current understanding of cytomegalovirus infection in immunocompetent individuals
Q73312003Cytomegalovirus (CMV) DNA amplification from plasma compared with CMV pp65 antigen (ppUL83) detection in leukocytes for early diagnosis of symptomatic CMV infection in kidney transplant patients
Q40424165Cytomegalovirus Infection in Marrow Transplantation
Q37139100Cytomegalovirus antigenemia: clinical correlations in transplant recipients and in persons with AIDS.
Q74009083Cytomegalovirus cultured from different major leukocyte subpopulations: association with clinical features in CMV immunoglobulin G-positive renal allograft recipients
Q73407599Cytomegalovirus diagnosis in renal and bone marrow transplant recipients: the impact of molecular assays
Q38128718Cytomegalovirus disease of the upper gastrointestinal tract in patients with rheumatic diseases: a case series and literature review
Q34743437Cytomegalovirus infections
Q33807009Dense bodies of human cytomegalovirus induce both humoral and cellular immune responses in the absence of viral gene expression
Q40820558Detection of cytomegalovirus proteins by flow cytometry in the blood of patients undergoing hematopoietic stem cell transplantation
Q67492071Detection of cytomegalovirus‐infected cells by flow cytometry and fluorescence in suspension hybridisation (FLASH) using DNA probes labeled with biotin by polymerase chain reaction
Q72416843Detection of human cytomegalovirus in urine samples by cell culture, early antigen assay and polymerase chain reaction
Q34102747Diagnosis and management of human cytomegalovirus infection in the mother, fetus, and newborn infant
Q39997572Dissemination of rat cytomegalovirus through infected granulocytes and monocytes in vitro and in vivo
Q34365016Functional interaction between the pp71 protein of human cytomegalovirus and the PML-interacting protein human Daxx
Q39664628High variability between results of different in-house tests for cytomegalovirus (CMV) monitoring and a standardized quantitative plasma CMV PCR assay.
Q39809696Human antibody reactivity against the lower matrix protein (pp65) produced by cytomegalovirus
Q35140023Human cytomegalovirus (HCMV) infection of endothelial cells promotes naive monocyte extravasation and transfer of productive virus to enhance hematogenous dissemination of HCMV
Q35856014Human cytomegalovirus carries serine/threonine protein phosphatases PP1 and a host-cell derived PP2A
Q37422612Human cytomegalovirus induces monocyte differentiation and migration as a strategy for dissemination and persistence
Q35886438Human cytomegalovirus tegument protein pp71 (ppUL82) enhances the infectivity of viral DNA and accelerates the infectious cycle
Q39809597Humoral immune response against human cytomegalovirus (HCMV)-specific proteins after HCMV infection in lung transplantation as detected with recombinant and naturally occurring proteins.
Q40038064Identification of binding sites for the 86-kilodalton IE2 protein of human cytomegalovirus within an IE2-responsive viral early promoter.
Q44820780Longitudinal monitoring of latent and active human cytomegalovirus infections in peripheral blood of heart transplant recipients by single-tube nested RT-PCR.
Q39960613Molecular, biological, and in vivo characterization of the guinea pig cytomegalovirus (CMV) homologs of the human CMV matrix proteins pp71 (UL82) and pp65 (UL83).
Q72126129Morphological and cytochemical analysis of human cytomegalovirus inoculum: correlation of free particles in inoculum with counterparts in infected cells
Q34973821Novel real-time monitoring system for human cytomegalovirus-infected cells in vitro that uses a green fluorescent protein-PML-expressing cell line
Q39868792Nuclear targeting of the tegument protein pp65 (UL83) of human cytomegalovirus: an unusual bipartite nuclear localization signal functions with other portions of the protein to mediate its efficient nuclear transport
Q44245356Nucleocytoplasmic shuttling and CRM1-dependent MHC class I peptide presentation of human cytomegalovirus pp65.
Q33641664Polo-like kinase 1 as a target for human cytomegalovirus pp65 lower matrix protein
Q44033391Primary immunosuppression with tacrolimus and mycophenolate mofetil versus cyclosporine and azathioprine in heart transplant recipients
Q35868126Proteins associated with purified human cytomegalovirus particles
Q39468915Quantitation of cytomegalovirus: methodologic aspects and clinical applications.
Q72389742Rapid detection of cytomegalovirus infection in immunocompromised patients
Q74319008Semi-quantitative detection of cytomegalovirus DNA from native serum and plasma by nested PCR: influence of DNA extraction procedures
Q35858175Stably expressed antisense RNA to cytomegalovirus UL83 inhibits viral replication.
Q39555791Standardization of the human cytomegalovirus antigenemia assay by means of in vitro-generated pp65-positive peripheral blood polymorphonuclear leukocytes
Q41991559Subviral dense bodies of human cytomegalovirus stimulate maturation and activation of monocyte-derived immature dendritic cells.
Q37183914Tegument proteins of human cytomegalovirus
Q39871910The dominant phosphoprotein pp65 (UL83) of human cytomegalovirus is dispensable for growth in cell culture
Q71447591The intracellular localization of human cytomegalovirus DNA in peripheral blood leukocytes during active infections by high-resolution fluorescence in situ hybridization
Q79293887The matrix protein pp65341‐350: a peptide that induces ex vivo stimulation and in vitro expansion of CMV‐specific CD8+ T cells in subjects bearing either HLA‐A*2402 or A*0101 allele
Q72434754The role of the major tegument protein VP8 of bovine herpesvirus-1 in infection and immunity
Q54120380Use of the human cytomegalovirus (HCMV) antigenemia assay for diagnosis and monitoring of HCMV infections and detection of antiviral drug resistance in the immunocompromised.
Q39552968Utility of major leukocyte subpopulations for monitoring secondary cytomegalovirus infections in renal-allograft recipients by PCR.
Q84333283Visualization of the dynamic multimerization of human Cytomegalovirus pp65 in punctuate nuclear foci

Search more.